FDA classifies recall of Medtronic embolization devices as 'most serious'
The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's embolization device as "most serious", ...
Becker's Hospital Review1h
Medtronic recalls embolization devices; 4 deaths reported
Medtronic has recalled certain Pipeline Vantage Embolization Devices with Shield Technology due to an increased risk of ...
MedTech Dive8h
Medtronic recalls embolization devices tied to 17 injuries, 4 deaths
Medtronic will remove one model of Pipeline Vantage devices from where they’re used and sold and will update the instructions ...
American Hospital Association3h
FDA issues recall on Medtronic embolization devices
The Food and Drug Administration has identified a Class I recall of Medtronic Neurovascular 027 Compatible Pipeline Vantage ...
Modern Healthcare9h
FDA deems Medtronic’s Pipeline Vantage recall ‘most serious’
The recall, which affects two models of Pipeline Vantage embolization devices, is linked to 17 injuries and four deaths.
FDA issues Medtronic embolization device recall and correction notice
In a notice posted to the agency’s website, the FDA noted that on January 30, 2025, Medtronic (MDT) Neurovascular sent all affected customers ...
Endovascular Today1d
Medtronic Recalls Pipeline Vantage 027, Updates IFU for Pipeline Vantage 021
The FDA announced that Medtronic initiated a device recall and correction for embolization devices. The FDA has identified ...
Targeted Oncology8d
Current Treatment Practices in Embolization-Eligible HCC
Panelists discuss how systemic therapy plays a crucial role in embolization-eligible hepatocellular carcinoma (HCC), ...
Medtronic slips after FDA notice on product recall (update)
Shares of Medtronic (NYSE:MDT) reached a session low on Tuesday after the U.S. Food and Drug Administration (FDA) announced a ...
Taiwan News10h
Terumo Neuro Celebrates 15 Years of the WEB™ Device: A Game-Changing Innovation in Aneurysm Treatment
Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, proudly marks ...
Shape Memory Medical’s President and CEO to present at LSI USA
Shape Memory Medical Inc., developer of custom shape memory polymers for endovascular markets, announced that Edward "Ted" Ruppel, President and CEO, is scheduled to speak on Wednesday, March 19th, ...
Endovascular Today8d
Instylla Completes FDA PMA Submission for Embrace Hydrogel Embolic System
Instylla, Inc. announced that it recently submitted the final module of its premarket approval (PMA) application to the FDA ...